Get Metropolis Healthcare with full year of free testing at just ₹4999
Need help? Talk to our expert.
WhatsApp
Maternal Screen-1st Trimester Dual Marker Test (Serum) _FMF
₹ 2,700
Maternal Screen-1st Trimester Dual Marker Test (Serum) _FMF
₹ 2,700
Booked 51+ booked in last 3 days

Maternal Screen-1st Trimester Dual Marker Test (Serum) _FMF

Also Known As :

Report
Report next day 09:00 pm
Fasting
Fasting no
Recommended for
Recommended for female
Maternal screen (Dual Marker) - 1st Trimester, Serum
₹ 2,700

PAPP-A (pregnancy-associated plasma protein-A) and free hCG (human chorionic gonadotropin) are biomarkers used in prenatal screening for Down syndrome, Edwards syndrome, and Patau syndrome. Their levels in maternal blood help assess the risk of chromosomal abnormalities in developing foetuses.

Frequently asked questions

Find quick answers to the most common questions about health tests, bookings, and reports.

This test measures the levels of PAPPa (pregnancy-associated plasma protein A) and Free HCG (human chorionic gonadotropin) in a pregnant woman's blood. PAPPa is produced by the placenta, while Free HCG is produced by the developing baby. The levels of these markers can help identify chromosomal abnormalities in the baby.

  • This test is done to:
  • Screen for chromosomal abnormalities in the 1st trimester
  • Assess risk for Down syndrome, Edwards syndrome, and Patau syndrome
  • Screen for Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome)
  • Guide doctors in providing suitable care and support

This test is recommended for pregnant women between 8 to 13.6 weeks of gestation. It is suitable for all pregnant women who want to assess their baby's risk for chromosomal abnormalities. Additionally, it may be suggested for women with a history of previous chromosomal abnormalities or those at higher risk based on certain genetic factors.

The test results are interpreted based on the levels of PAPPa and Free HCG in the blood. Abnormal results may indicate an increased risk of chromosomal abnormalities in the baby, but it does not provide a definitive diagnosis. Further diagnostic tests like genetic counselling or invasive prenatal testing may be recommended to confirm any abnormalities.

Book a Home Visit Now

Book any blood test or health checkup and get tested at the comfort of your home.

Why Metropolis Healthcare?

Metropolis has been present for over 43 years in the market.

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

NABL & CAP

Accredited labs

Advanced Labs

210+

Advanced Labs

Trusted by

750+ Cities

Global Presence

Scientific Officers

2,000+

Scientific Officers

Proficiency Testing

4,100+

Test & Profiles

Latest Blogs & News

Stay informed with our expert insights and updates.

About Us

Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.

In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.

Do you have any queries? Or call us now at 0804-8911-400

Proceed
0 items
0
Go to Cart